Meeting
2023 ASCO Annual Meeting
Association between locoregional failure and NFE2L2/KEAP1/CUL3 pathway mutations in NRG/RTOG 9512: A randomized trial of hyperfractionation vs. conventional fractionation in T2N0 glottic squamous cell carcinoma (SCC).
Authors
Li Guan
Stanford University, Stanford, CA
Li Guan , Pedro A. Torres-Saavedra , Xiaobei Zhao , Michael B. Major , Brittany J. Holmes , Ngan Nguyen , Parasakthy Kumaravelu , Tim Hodge , Maximilian Diehn , Jose Zevallos , Bahman Emami , Stephen M. Sagar , William H. Morrison , Christopher J. Schultz , Jimmy J. Caudell , Christopher U. Jones , Sue S. Yom , Jonathan Harris , Quynh-Thu Le , David N. Hayes
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Head and Neck Cancer
Track
Head and Neck Cancer
Sub Track
Biologic Correlates
Clinical Trial Registration Number
NCT00002727
Citation
J Clin Oncol 41, 2023 (suppl 16; abstr 6054)
DOI
10.1200/JCO.2023.41.16_suppl.6054
Abstract #
6054
Poster Bd #
46
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Atezolizumab plus tiragolumab in combination with chemoradiotherapy in localized squamous cell carcinoma of the anal canal: TIRANUS (GEMCAD-2103) trial.
First Author: Jaume Capdevila
Poster
2019 Genitourinary Cancers Symposium
Association of next generation sequencing characteristics of MIBC specimens with clinical outcomes: The USC experience.
First Author: Arnab Basu
Poster
2014 ASCO Annual Meeting
Inferior local control for T2bN0 glottic carcinoma with impaired mobility treated with radiation alone: A need for more chemotherapy?
First Author: Priyanka Bhateja
Poster
2014 ASCO Annual Meeting
The CXCL12/CXCR4 pathway, bone marrow-derived myeloid cells, and survival in locally advanced cervical cancer.
First Author: Naz Chaudary